Nidek Co., LTD.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$135Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
21clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $25K
2020 $17K
2021 $32K
2022 $27K
2023 $16K
2024 $9,762
2025 $7,923

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Ophthalmology $119K
Uveitis and Ocular Inflammatory Disease $13K
Retina Specialist $2,000
Optometrist $1,000

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Kenneth Hoffer Santa Monica, CA Ophthalmology $73,022.67
Srinivas Sadda Pasadena, CA Ophthalmology $19,500.00
Nadia Waheed Boston, MA Uveitis and Ocular Inflammatory Disease $13,000.00
Hanna Shammas Lynwood, CA Ophthalmology $10,000.00
Robert Ritch New York, NY Ophthalmology $9,060.00
Kenneth Freund New York, NY Ophthalmology $2,500.00
Howard Barnebey Bellevue, WA Ophthalmology $2,000.00
Suber Huang Cleveland, OH Retina Specialist $2,000.00
Jennifer Unger Oak Creek, WI Ophthalmology $1,500.00
Daniel Laroche New York, NY Ophthalmology $1,500.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.